Case Study: EV-ICD and Epicardial Ablation in a 40-Year-Old Patient - Report - MDSpire
Advertisement
Case Study: EV-ICD and Epicardial Ablation in a 40-Year-Old Patient
A 40-year-old man presented with palpitations and dizziness that had been ongoing for several days. EMS found that he was in sustained monomorphic ventricular tachycardia and performed cardioversion to restore regular heart rhythm. In conversation with care providers, the patient recalled a prior episode of chest pain that had lasted for several days. He was brought to Temple Health for further care.
Clinical Report: EV-ICD and Epicardial Ablation in a 40-Year-Old Patient
Overview
This case study details the successful use of an extravascular implantable cardioverter-defibrillator (EV-ICD) and epicardial ablation in a 40-year-old man with sustained monomorphic ventricular tachycardia (VT) following a myocardial infarction. The patient experienced significant improvement in his condition post-procedure, with no further episodes of VT reported six months later.
Background
Ventricular tachycardia (VT) is a serious arrhythmia that can lead to sudden cardiac death, particularly in patients with a history of myocardial infarction. The management of VT often requires advanced interventions such as implantable cardioverter-defibrillators (ICDs) and catheter ablation. The EV-ICD represents a novel approach that minimizes complications associated with traditional transvenous leads, making it particularly suitable for younger patients and those at risk of infections.
Data Highlights
No numerical data available in the source material.
Key Findings
The patient presented with sustained monomorphic VT and a history of anterior myocardial infarction.
The EV-ICD was successfully implanted, providing anti-tachycardia pacing (ATP) and defibrillation capabilities.
Epicardial ablation was performed due to the presence of a left ventricular thrombus, which complicated conventional ablation approaches.
Post-procedure, the patient did not experience any further episodes of VT over a six-month follow-up period.
EV-ICD is contraindicated in patients with prior sternotomy but is suitable for most other candidates eligible for ICD therapy.
The combination of EV-ICD and epicardial ablation is a novel approach that had not been previously documented in the U.S.
Clinical Implications
The successful application of the EV-ICD and epicardial ablation in this case highlights the potential for innovative treatment strategies in managing complex VT cases. Clinicians should consider the EV-ICD for younger patients and those with a high risk of lead-related complications, while also being aware of the unique challenges posed by left ventricular thrombus during ablation procedures.
Conclusion
This case underscores the importance of advanced techniques in the management of ventricular tachycardia, particularly in patients with complex cardiac histories. The combination of EV-ICD and epicardial ablation may offer a promising solution for similar cases in the future.
Population-based cohort shows higher rates of cardiac arrhythmias and coronary artery disease following nonhospitalized infections, with sex-specific differences.
